Skip to main content
MYGN logo

MYGN · Myriad Genetics Inc · Investor Relations

Track MYGN — free
$6.63 +0.00 (+0.00%) Q2 2026 earnings call transcript
Market Cap
$634.16M
Shares
95.65M
Volume · Oct 29 414.26K Avg daily vol (3M) 2.63M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-04 00:00 UTC Q3 Earnings conference call (announced in 8-K) Earnings call

Past events

Date Event Type
2026-09-10 Wells Fargo Healthcare Conference Conference
2026-08-04 Myriad Genetics Second Quarter 2026 Financial Earnings Earnings call
2026-07-30 Myriad Genetics Second Quarter 2026 Financial Earnings Earnings call
2026-05-05 Myriad Genetics First Quarter 2026 Financial Earnings Earnings call
2026-03-11 Barclays 28th Annual Global Healthcare Conference Conference
2026-03-10 Leerink Partners Global Healthcare Conference Conference
2026-02-23 Q4 FY2025 Earnings conference call (announced in 8-K) Earnings call

Source: https://investor.myriad.com/

Key facts CIK 899923 CUSIP 62855J104 13F (30d) 25 filings 25 filers Visit website Investor relations